UPDATE 1-Hong Kong’s mom-and-pop investors squeeze funds as IPOs sizzle

By August 2, 2020 Press Coverage

Excerpt: “It is a consensus among institutional investors that valuation for the majority of the biotech companies listing in Hong Kong are stretched,” according to Aequitas Research co-founder Ke Yan, who publishes on the SmartKarma platform.

Scott Murdoch • (Opens in a new window) ⧉

Are you a Professional Journalist?

The Smartkarma Press Pass is a special login created exclusively for pre-approved professional journalists. It allows a journalist to access content on the platform and use all the powerful search and discovery functionality available. Journalists can excerpt and quote from the content on Smartkarma to enrich and support their articles.

Request your Press Pass Now